Arcadia Biosciences, Inc. (RKDA) › Operating Cash FlowArcadia Biosciences, Inc. (RKDA) — Operating Cash FlowAnnual figures by period end, from SEC filings.2017-12-31: -$13.96M2018-12-31: -$13.63M2019-12-31: -$17.20M2020-12-31: -$30.22M2021-12-31: -$25.87M2022-12-31: -$13.98M2023-12-31: -$15.29M2024-12-31: -$9.63M2025-12-31: -$4.74M-$4.74M2017-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31-$4.74M—2026-03-26From 2025-01-012024-12-31-$9.63M—2026-03-26From 2024-01-012023-12-31-$15.29M—2025-03-25From 2023-01-012022-12-31-$13.98M—2024-03-28From 2022-01-012021-12-31-$25.87M—2023-03-30From 2021-01-012020-12-31-$30.22M—2022-03-31From 2020-01-012019-12-31-$17.20M—2021-03-31From 2019-01-012018-12-31-$13.63M—2020-03-25From 2018-01-012017-12-31-$13.96M—2019-04-01From 2017-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)